Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what estimate (a) his Department and (b) the National Institute for Health and Care Excellence (NICE) have made of the savings to the NHS which have resulted from NICE rejecting treatments for routine use on the NHS; if he will list for each medicine which NICE has rejected for use on the NHS in the last four years the estimated cost saving which resulted from that decision; and if he will make a statement.

Neither the Department nor the National Institute for Health and Care Excellence (NICE) have made any such estimate.

NICE publishes costing templates to help support implementation of positive technology appraisal recommendations, but does not prepare information on the possible financial impact on the National Health Service where a treatment is not recommended in NICE technology appraisal guidance.